Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Osteoporosis 2Leukemia 2Breast Neoplasms 2Vitamin D Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Ovarian Neoplasms 1Obesity 1Myelodysplastic Syndromes 1Lymphoma 1Arthralgia 1

Interventions

Zoledronic Acid 14Vitamin D 8Risedronic Acid 8Letrozole 7Calcium 7Calcium Carbonate 5Absorptiometry, Photon 5Cholecalciferol 4Denosumab 3Alendronate 3bicalutamide 2Resistance Training 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Calcium Gluconate 2Calcium Citrate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1parathyroid hormone-related peptide (1-36) 1X-Rays 1Toremifene 1Technetium 1Raloxifene Hydrochloride 1Radiotherapy 1Progestins 1Lysine Acetyltransferase 5 1Linseed Oil 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Osteoporosis × Calcium Citrate × Clear all
NCT00354302 2020-04-02

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Canadian Cancer Trials Group

Phase 3 Completed
497 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡